PIN1 and cancer: Although ATO and ATRA each have other anticancer mechanisms16,50,51, their cooperative Pin1 inhibition likely plays a major role in mediating their ability to block multiple cancer-driving pathways and eliminate TICs in TNBC, two major sources of drug resistance in current cancer therapy (Fig. 8).